General Anesthesia Practice Questions

Q: A patient with liver cirrhosis is scheduled for surgery. Which anesthetic agent should be avoided?

Halothane. ***Halothane*** - **Halothane** metabolism produces **trifluoroacetylated proteins**, which can lead to severe **hepatotoxicity**, a critical concern in patients with pre-existing liver disease like cirrhosis. - Its use can exacerbate liver dysfunction due to its **extensive hepatic metabolism** compared to newer volatile anesthetics. *Sevoflurane* - **Sevoflurane** undergoes minimal hepatic metabolism (around 3-5%) and is primarily eliminated via the lungs, making it a safer option for patients with liver disease. - It has a good safety profile with a low incidence of hepatotoxicity. *Propofol* - **Propofol** is primarily metabolized in the liver, but its high hepatic clearance and non-cumulative nature make it suitable for patients with liver cirrhosis, although dosage adjustments may be necessary. - It does not produce toxic metabolites that significantly harm the liver. *Isoflurane* - **Isoflurane** is very minimally metabolized by the liver (around 0.2%), with the majority eliminated unchanged via the lungs. - This low hepatic metabolic load makes it a safe choice for patients with liver impairment.

Q: Which drug is used to reverse the effects of non-depolarizing muscle relaxants?

Neostigmine. ***Neostigmine*** - **Neostigmine** is an **acetylcholinesterase inhibitor** that increases the amount of acetylcholine at the neuromuscular junction. - This increased acetylcholine can then compete with **non-depolarizing muscle relaxants** for receptors, reversing their effects. *Atropine* - **Atropine** is an **anticholinergic drug** that blocks muscarinic receptors. - It is often co-administered with neostigmine to counteract the **parasympathetic side effects** of neostigmine, such as bradycardia and increased salivation, but does not reverse muscle relaxation directly. *Glycopyrrolate* - **Glycopyrrolate** is also an **anticholinergic drug** similar to atropine, but with less central nervous system penetration. - It is co-administered with neostigmine for the same reason as atropine, to mitigate the **cholinergic side effects** of neostigmine, not to reverse muscle paralysis. *Edrophonium* - **Edrophonium** is a short-acting **acetylcholinesterase inhibitor** historically used to reverse non-depolarizing muscle relaxants. - While it can reverse muscle relaxation, it has a **shorter duration of action** compared to neostigmine and is less commonly used for this purpose in modern practice.

Q: In a patient with end-stage renal disease undergoing surgery, which anesthetic agent requires the most careful consideration regarding dosing and monitoring?

Propofol. ***Propofol*** - While propofol itself is primarily metabolized in the liver, its **excipient, lipid emulsion**, can contribute to hypertriglyceridemia and fluid overload, which are significant concerns in **end-stage renal disease (ESRD)** patients. - Its high protein binding can be altered in uremia, potentially increasing the **free drug concentration** and enhancing its effects, requiring careful titration. *Etomidate* - Etomidate is primarily metabolized by **hepatic enzymes and plasma esterases** into inactive metabolites, with minimal renal excretion of the parent drug. - Its use can lead to **adrenal suppression** by inhibiting 11-beta-hydroxylase, a concern in critically ill patients but not directly related to renal clearance in ESRD. *Ketamine* - Ketamine is metabolized by the **liver** via N-demethylation to **norketamine**, which has some anesthetic activity but is primarily excreted renally. - While its metabolites are renally cleared, the **parent drug** itself is largely unaffected by renal impairment, and its hemodynamic stability can be advantageous in ESRD. *Sevoflurane* - Sevoflurane is primarily eliminated via the **lungs**, with very minimal metabolism in the liver. - However, its metabolism produces **compound A**, which can be nephrotoxic in animals (though less so in humans) and its accumulation is a theoretical concern in severely compromised kidneys, but it's not a primary factor affecting dosing in ESRD.

Q: A patient with chronic kidney disease is undergoing surgery. Which induction agent should be used with caution?

Thiopental. ***Thiopental*** - Thiopental is primarily metabolized by the liver, but its metabolites are **renally excreted**. In patients with **chronic kidney disease (CKD)**, these metabolites can accumulate, leading to prolonged sedation and delayed emergence from anesthesia. - Thiopental also causes **vasodilation** and **myocardial depression**, which can be poorly tolerated in CKD patients who often have underlying cardiovascular compromise. *Propofol* - Propofol is rapidly metabolized by the **liver** into inactive metabolites, with minimal renal excretion of the active drug. This makes it a generally safe choice for induction in patients with **CKD**. - It provides a smooth induction and rapid recovery, and its **hemodynamic effects** are predictable and manageable. *Ketamine* - Ketamine is metabolized by the liver into active and inactive metabolites, with subsequent renal excretion. While **some renal excretion** of metabolites occurs, it is generally considered safe for induction in CKD patients at usual doses. - Ketamine tends to **maintain blood pressure** and heart rate, which can be beneficial in patients with cardiovascular instability, often seen in CKD. *Etomidate* - Etomidate is primarily metabolized by **hepatic enzymes** into inactive metabolites, which are then renally excreted. Its pharmacokinetics are largely unaffected by renal impairment, making it generally safe for induction in CKD patients. - It provides **hemodynamic stability**, which is particularly advantageous in patients with compromised cardiovascular function or significant volume depletion.

Q: During a surgical procedure, a 70-year-old male develops hypotension and bradycardia after the administration of a muscle relaxant. What is the most likely cause?

Succinylcholine. ***Succinylcholine*** - **Succinylcholine** can cause **bradycardia** and **hypotension** due to its direct stimulation of **muscarinic receptors** at the SA node, especially with repeat doses or in susceptible individuals. - This effect is more pronounced in **children** and in adults receiving a second dose within a short period, leading to a **parasympathomimetic response**. *Vecuronium* - **Vecuronium** is an **intermediate-acting non-depolarizing neuromuscular blocker** that is generally associated with minimal cardiovascular effects. - It does not typically cause **bradycardia** or **hypotension** at clinical doses, as it lacks significant **histamine release** or **ganglionic blockade**. *Atracurium* - **Atracurium** is an **intermediate-acting non-depolarizing neuromuscular blocker** that can cause **histamine release**, leading to **hypotension** and **tachycardia** (not bradycardia). - The observed **bradycardia** in the patient makes atracurium an unlikely cause, as its cardiovascular effects are primarily related to vasodilation from **histamine**. *Rocuronium* - **Rocuronium** is a **rapid-onset, intermediate-acting non-depolarizing neuromuscular blocker** that has minimal cardiovascular effects. - It is known for its stability and does not typically induce **bradycardia** or **hypotension**, making it a less likely cause for the patient’s symptoms.

Q: Which of the following is a contraindication for the use of succinylcholine?

Susceptibility to malignant hyperthermia. ***Susceptibility to malignant hyperthermia*** - Succinylcholine, a **depolarizing neuromuscular blocker**, is a potent trigger for **malignant hyperthermia** in susceptible individuals. - Malignant hyperthermia is a life-threatening, **hypermetabolic crisis** characterized by muscle rigidity, hyperthermia, tachycardia, and acidosis. *Severe cases of myasthenia gravis* - Patients with myasthenia gravis, an **autoimmune disorder affecting neuromuscular junctions**, are generally more sensitive to depolarizing and non-depolarizing neuromuscular blockers. - While caution is advised, it is not an absolute contraindication but rather requires **reduced doses** and careful monitoring to avoid prolonged blockade. *High potassium levels (severe hyperkalemia)* - Succinylcholine causes a transient **increase in serum potassium levels** due to the efflux of potassium from muscle cells. - In patients with pre-existing severe hyperkalemia, this can lead to **life-threatening arrhythmias** or cardiac arrest, making it a relative contraindication. *Low calcium levels (hypocalcemia)* - Hypocalcemia can potentially **potentiate the effects of neuromuscular blockers**, but it is not typically considered a direct contraindication for succinylcholine use. - The primary concern with succinylcholine relates to potassium efflux and its triggers for malignant hyperthermia.

Q: A patient under general anesthesia develops tachycardia and hypertension following the administration of an inhalational anesthetic. Which agent is most likely responsible?

Desflurane. ***Desflurane*** - **Desflurane** is well-known for causing a **sympathetic nervous system stimulation** at higher concentrations or with rapid increases in concentration, leading to **tachycardia** and **hypertension**. - This effect is often due to its **pungent odor** and rapid onset, which can irritate airways and trigger reflex responses. *Halothane* - **Halothane** is more associated with **myocardial depression** and can cause **bradycardia** rather than tachycardia. - It also has a higher propensity for causing **arrhythmias**, particularly in the presence of exogenous catecholamines. *Sevoflurane* - **Sevoflurane** is known for its **smooth induction** and **minimal cardiovascular depression**, making it suitable for pediatric patients. - While it can cause some vasodilation, it typically does not lead to significant tachycardia or hypertension unless in very high concentrations or in specific patient populations. *Isoflurane* - **Isoflurane** can cause **dose-dependent peripheral vasodilation**, which can lead to a compensatory increase in heart rate. - However, the hypertension and marked tachycardia described are less characteristic of isoflurane than of desflurane's sympathetic stimulation.

Q: Which crystalloid solution is most commonly used in perioperative fluid management?

Ringer's lactate. ***Ringer's lactate*** - **Ringer's lactate** is a **balanced salt solution** containing electrolytes (sodium, chloride, potassium, calcium) and lactate, which is metabolized to bicarbonate. - Its composition is relatively similar to plasma, making it a preferred choice for **volume expansion** and replacement of fluid losses in the perioperative setting due to a lower risk of metabolic acidosis compared to normal saline. *Normal saline* - **Normal saline (0.9% NaCl)** contains a higher chloride concentration than plasma, which can lead to **hyperchloremic metabolic acidosis** with large-volume administration. - While commonly used, its unbalanced electrolyte profile makes it less physiologically ideal than Ringer's lactate for routine perioperative fluid management. *Dextrose 5%* - **Dextrose 5% in water (D5W)** is primarily used as a source of **free water** and to provide minimal caloric support, or for maintaining patency of intravenous lines. - It is not an effective volume expander as dextrose is rapidly metabolized, leaving behind hypotonic fluid that distributes throughout all fluid compartments. *Albumin* - **Albumin** is a **colloid solution**, meaning it contains large molecules that remain in the intravascular space and exert oncotic pressure. - It is typically reserved for specific situations like **hypoalbuminemia**, large volume resuscitation in critically ill patients, or conditions where crystalloids are insufficient, rather than routine perioperative fluid management.

Q: A 55-year-old male with a history of chronic liver disease is scheduled for an emergency laparotomy. Which anesthetic agent is preferred to minimize hepatic metabolism?

Etomidate. ***Etomidate*** - **Etomidate** is preferred in patients with chronic liver disease because its metabolism primarily occurs via **plasma esterases**, rather than hepatic pathways, minimizing further liver stress. - It also provides good **cardiovascular stability**, which is beneficial in patients who might have compromised hemodynamics due to their liver disease or the emergency nature of surgery. *Propofol* - **Propofol** undergoes extensive **hepatic metabolism** and can lead to prolonged sedation in patients with significant liver impairment, increasing the risk of accumulation. - While suitable for many patients, the liver's compromised function in **chronic liver disease** makes it less ideal when considering minimized hepatic metabolism. *Thiopentone* - **Thiopentone** (Thiopental) mainly relies on **hepatic metabolism** for its elimination, which would be significantly prolonged in a patient with chronic liver disease. - This can result in a **prolonged awakening time** and increased risk of respiratory depression in patients with impaired liver function. *Sevoflurane* - **Sevoflurane** is an inhaled anesthetic that is primarily eliminated by the lungs, but a small percentage (about 3-5%) is metabolized in the liver, forming **fluoride ions**. - While generally considered safe for the liver, its minimal hepatic metabolism still makes it less ideal than an agent relying solely on **extrahepatic metabolism** in severely compromised liver function.

Q: A patient undergoing craniotomy for tumor resection under general anesthesia develops hyperkalemia. Which muscle relaxant is most likely responsible for this condition?

Succinylcholine. **Succinylcholine** * **Succinylcholine** is a depolarizing muscle relaxant that can cause **hyperkalemia** by transiently binding to nicotinic acetylcholine receptors, leading to widespread depolarization and potassium efflux from muscle cells. * This effect is particularly pronounced in patients with conditions like burns, crush injuries, stroke, or severe muscle trauma due to an **upregulation of acetylcholine receptors**, increasing potassium release. * *Atracurium* * **Atracurium** is a non-depolarizing neuromuscular blocker that typically does not cause significant **hyperkalemia** because it acts as an antagonist at the acetylcholine receptor without causing depolarization. * It undergoes **Hofmann elimination** and ester hydrolysis, making its elimination independent of renal or hepatic function, which is useful in certain patient populations. * *Rocuronium* * **Rocuronium** is a non-depolarizing neuromuscular blocker that competitively blocks acetylcholine receptors, preventing muscle contraction without causing **depolarization or potassium release**. * It has a **rapid onset of action** and is primarily eliminated by the liver, making it a common choice for rapid sequence intubation when succinylcholine is contraindicated. * *Cisatracurium* * **Cisatracurium** is an isomer of atracurium and is also a non-depolarizing neuromuscular blocker that does not cause **hyperkalemia**. * It is primarily metabolized by **Hofmann elimination**, making it a good choice for patients with renal or hepatic dysfunction, similar to atracurium but with fewer histamine release properties.

Question 1

A patient with liver cirrhosis is scheduled for surgery. Which anesthetic agent should be avoided?

Accepted Answer

Halothane

Answer

Sevoflurane

Answer

Propofol

Answer

Isoflurane

Question 2

Which drug is used to reverse the effects of non-depolarizing muscle relaxants?

Accepted Answer

Neostigmine

Answer

Atropine

Answer

Glycopyrrolate

Answer

Edrophonium

Question 3

In a patient with end-stage renal disease undergoing surgery, which anesthetic agent requires the most careful consideration regarding dosing and monitoring?

Accepted Answer

Propofol

Answer

Etomidate

Answer

Ketamine

Answer

Sevoflurane

Question 4

A patient with chronic kidney disease is undergoing surgery. Which induction agent should be used with caution?

Accepted Answer

Thiopental

Answer

Propofol

Answer

Ketamine

Answer

Etomidate

Question 5

During a surgical procedure, a 70-year-old male develops hypotension and bradycardia after the administration of a muscle relaxant. What is the most likely cause?

Accepted Answer

Succinylcholine

Answer

Atracurium

Answer

Vecuronium

Answer

Rocuronium

Question 6

Which of the following is a contraindication for the use of succinylcholine?

Accepted Answer

Susceptibility to malignant hyperthermia

Answer

Low calcium levels (hypocalcemia)

Answer

Severe cases of myasthenia gravis

Answer

High potassium levels (severe hyperkalemia)

Question 7

A patient under general anesthesia develops tachycardia and hypertension following the administration of an inhalational anesthetic. Which agent is most likely responsible?

Accepted Answer

Desflurane

Answer

Halothane

Answer

Sevoflurane

Answer

Isoflurane

Question 8

Which crystalloid solution is most commonly used in perioperative fluid management?

Accepted Answer

Ringer's lactate

Answer

Normal saline

Answer

Dextrose 5%

Answer

Albumin

Question 9

A 55-year-old male with a history of chronic liver disease is scheduled for an emergency laparotomy. Which anesthetic agent is preferred to minimize hepatic metabolism?

Accepted Answer

Etomidate

Answer

Thiopentone

Answer

Propofol

Answer

Sevoflurane

Question 10

A patient undergoing craniotomy for tumor resection under general anesthesia develops hyperkalemia. Which muscle relaxant is most likely responsible for this condition?

Accepted Answer

Succinylcholine

Answer

Atracurium

Answer

Rocuronium

Answer

Cisatracurium

General Anesthesia — MCQs

General Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?